Validation of proposed criteria for progressive pulmonary fibrosis

JV Pugashetti, A Adegunsoye, Z Wu… - … journal of respiratory …, 2023 - atsjournals.org
… published by the American Thoracic Society, European Respiratory Society, Japanese …
, with only modest differences in TFS association. These differences were driven primarily by …

Mycophenolate in Patients with Systemic Sclerosis–associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

D Herman, M Ghazipura, H Barnes… - … American Thoracic …, 2024 - atsjournals.org
… There were no significant differences between mycophenolate and cyclophosphamide, …
There were no differences in mortality, disease progression, or quality of life compared with …

Antifibrotic drug use in patients with idiopathic pulmonary fibrosis. Data from the IPF-PRO Registry

ML Salisbury, CS Conoscenti, DA Culver… - … American Thoracic …, 2020 - atsjournals.org
American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin
American Thoracic Association … registries could relate to differences in healthcare systems …

Awakening and breathing coordination: A mixed-methods analysis of determinants of implementation

GH Olsen, PM Gee, D Wolfe, C Winberg… - … American Thoracic …, 2023 - atsjournals.org
… We did not observe meaningful differences in implementation determinants across interview
sites based on adherence, apart from the small rural site, where low mechanical ventilation …

Idiopathic Pulmonary Fibrosis Incidentally Detected by Computed Tomography Scan as Interstitial Lung Abnormalities

T Bando, R Takei, J Fukihara, H Sasano… - … American Thoracic …, 2024 - atsjournals.org
… the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin
American Thoracic Association … and had no significant differences to graph trends in a …

Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

L Lancaster, V Cottin, M Ramaswamy… - … Journal of Respiratory …, 2024 - atsjournals.org
… In our prior investigation in healthy volunteers exposed to bexotegrast for 7 days (PLN-74809-109)
(30), there were no notable differences in the total leukocyte cell count or distribution …

Epidemiology of chronic obstructive pulmonary disease

L Ruvuna, A Sood - Clinics in Chest Medicine, 2020 - chestmed.theclinics.com
… 1 COPD may result from rapid lung function decline or inadequate growth and development
of the lung. 2 This disorder is still underdiagnosed by treating providers, and is sometimes …

Reticulation is a risk factor of progressive subpleural nonfibrotic interstitial lung abnormalities

Y Zhang, H Wan, L Richeldi, M Zhu… - … journal of respiratory …, 2022 - atsjournals.org
… No differences in radiological progression were identified between subpleural nonfibrotic ILAs
with reticulation in lower lung … An official American Thoracic Society/European Respiratory

[HTML][HTML] Masking the 6-minute walking test in the COVID-19 era

A Salles-Rojas, C Guzmán-Valderrábano… - … American Thoracic …, 2021 - atsjournals.org
… 6-MWTs according to American Thoracic Society/European Respiratory Society standards,
with a … No differences were observed in the meters walked, Sp O 2 , HR, dyspnea, or fatigue, …

Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection

L Li, E Henkle, BM Youngquist, S Seo… - … journal of respiratory …, 2024 - atsjournals.org
… who met American Thoracic Society/European Respiratory Society/European Society of …
No differences were detected in the CRISPR MAC signal of the healthy control and disease …